A Aforeworn
Forewarned is forearmed.
Home › Niches › Pharmacy & Controlled Substances › Change
High urgency

US-CONGRESS HR8170: MATCH Act

Detected August 21, 2026 · in Pharmacy & Controlled Substances

The MATCH Act introduces new requirements for pharmacies regarding prescription drug monitoring and e-prescribing, impacting compliance protocols and operational workflows.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 21, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: To be determined based on final enactment and implementation timeline.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

New compliance requirements related to prescription drug monitoring programs (PDMP) and e-prescribing standards.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies.

What you must do

Review and update compliance protocols to align with the new PDMP and e-prescribing requirements.

Deadline

To be determined based on final enactment and implementation timeline.

Source: https://www.congress.gov/bill/119th-congress/house-bill/8170

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances